Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors

Bone marrow is a major homing site for circulating epithelial tumor cells. The present study was aimed to assess the proliferative capacity of occult metastatic cells in bone marrow of patients with operable solid tumors especially with regard to their clinical outcome. We obtained bone marrow aspirates from 153 patients with carcinomas of the prostate (n = 46), breast (n = 45), colon (n = 33), and kidney (n = 29). Most of the patients (87%) had primary disease with no clinical signs of overt metastases [tumor-node-metastasis (TNM)-stage UICC (Union Internationale Contre le Cancer) I-III]. After bone marrow was cultured for 21–102 days under special cell culture conditions, viable epithelial cells were detected by cytokeratin staining in 124 patients (81%). The cultured epithelial cells harbored Ki-ras2 mutations and numerical chromosomal aberrations. The highest median number of expanded tumor cells was observed in prostate cancer (2,619 per flask). There was a significant positive correlation between the number of expanded tumor cells and the UICC-stage of the patients (P = 0.03) or the presence of overt metastases (P = 0.04). Moreover, a strong expansion of tumor cells was correlated to an increased rate of cancer-related deaths (P = 0.007) and a reduced survival of the patients (P = 0.006). In conclusion, the majority of cancer patients have viable tumor cells in their bone marrow at primary tumor diagnosis, and the proliferative potential of these cells determines the clinical outcome.

[1]  S. Braun,et al.  ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients. , 2001, Cancer research.

[2]  T. Reimer,et al.  Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Braun,et al.  Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  K. Schütze,et al.  Diagnosis of Papillary Thyroid Carcinoma Is Facilitated by Using an RT-PCR Approach on Laser-Microdissected Archival Material to Detect RET Oncogene Activation , 2001, Pathobiology.

[5]  P. Würl,et al.  Detection of cytokeratin-positive cells in bone marrow in breast cancer and colorectal carcinoma in comparison with other factors of prognosis. , 2000, Journal of hematotherapy & stem cell research.

[6]  G. Lahr.  RT-PCR from Archival Single Cells Is a Suitable Method to Analyze Specific Gene Expression , 2000, Laboratory Investigation.

[7]  G. Clark,et al.  The importance of being K-Ras. , 2000, Cellular signalling.

[8]  T. Dimpfl,et al.  Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. , 2000, The New England journal of medicine.

[9]  R. Cote,et al.  Detection and clinical importance of micrometastatic disease. , 1999, Journal of the National Cancer Institute.

[10]  F. Shanahan,et al.  Micrometastases in esophagogastric cancer: high detection rate in resected rib segments. , 1999, Gastroenterology.

[11]  Georgia Lahr,et al.  Identification of expressed genes by laser-mediated manipulation of single cells , 1998, Nature Biotechnology.

[12]  H. Juhl,et al.  Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. , 1997, Cancer research.

[13]  H. Allgayer,et al.  Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease. , 1997, Cancer research.

[14]  K. Pantel,et al.  Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases , 1996, The Lancet.

[15]  H. Allgayer,et al.  Individual development and uPA–receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer , 1995, Nature Medicine.

[16]  K. Pantel,et al.  Establishment of micrometastatic carcinoma cell lines: a novel source of tumor cell vaccines. , 1995, Journal of the National Cancer Institute.

[17]  W. Eiermann,et al.  Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. , 1994, British Journal of Cancer.

[18]  J. Izbicki,et al.  Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. , 1994, Journal of hematotherapy.

[19]  N. Davidson,et al.  Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. , 1993, Blood.

[20]  J. Izbicki,et al.  Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. , 1993, Journal of the National Cancer Institute.

[21]  G. Schlimok,et al.  Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients , 1992, The Lancet.

[22]  K. Pantel,et al.  Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. , 1991, European journal of cancer.

[23]  M L Lesser,et al.  Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  A. Kitzis,et al.  Detection of minority point mutations by modified PCR technique: a new approach for a sensitive diagnosis of tumor-progression markers. , 1989, Nucleic acids research.

[25]  G. Bepler,et al.  Establishment and identification of small cell lung cancer cell lines having classic and variant features. , 1985, Cancer research.